Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy

Maria Gabriela Morales*, Jaime Gutierrez, Claudio Cabello-Verrugio, Daniel Cabrera, Kenneth E. Lipson, Roel Goldschmeding, Enrique Brandan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

121 Scopus citations

Fingerprint

Dive into the research topics of 'Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology